HEALTHCARE
Teva settles opioid suits in Israel
Under the settlement, Teva's insurance company, which as far as is known is not Israeli, will pay the pharmaceutical company $40 million to fully close all potential claims.
Teva exec reveals the AI tools pharma really wants
Fantasies of an AI revolution in drugs have met the reality of the industry's conservatism. But Teva’s head of R&D offers a glimpse into the AI tools his company actually uses, and is looking for. Startups take note.
Teva again king of Tel Aviv castle
After a 130% rise in its share price in the last year, the pharmaceuticals company has left the big two banks and Nice a long way behind.